D
BetterLife Pharma Inc.
BETR
CNSX
D
Sell
2/27/2025Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 2/27/2025 due to an increase in the volatility index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 2/27/2025 due to an increase in the volatility index.
E
Sell
2/12/2025Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 2/12/2025 due to a decline in the volatility index and total return index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 2/12/2025 due to a decline in the volatility index and total return index.
D
Sell
1/6/2025Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 1/6/2025 due to an increase in the volatility index, solvency index and valuation index. Debt to equity declined from -0.1 to -0.11.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 1/6/2025 due to an increase in the volatility index, solvency index and valuation index. Debt to equity declined from -0.1 to -0.11.
E
Sell
12/26/2024Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 12/26/2024 due to a noticeable decline in the total return index and volatility index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 12/26/2024 due to a noticeable decline in the total return index and volatility index.
D
Sell
7/5/2024Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 7/5/2024 due to an increase in the volatility index, total return index and growth index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 7/5/2024 due to an increase in the volatility index, total return index and growth index.
E
Sell
6/14/2024Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 6/14/2024 due to a major decline in the solvency index, growth index and volatility index. Earnings per share declined from -$0.0013 to -$0.0084, the quick ratio declined from 0.02 to 0.01, and EBIT declined 5.13% from -$514.5 to -$540.9.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 6/14/2024 due to a major decline in the solvency index, growth index and volatility index. Earnings per share declined from -$0.0013 to -$0.0084, the quick ratio declined from 0.02 to 0.01, and EBIT declined 5.13% from -$514.5 to -$540.9.
D
Sell
6/4/2024Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 6/4/2024 due to an increase in the volatility index, total return index and valuation index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 6/4/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
5/20/2024Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 5/20/2024 due to a decline in the volatility index and valuation index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 5/20/2024 due to a decline in the volatility index and valuation index.
D
Sell
5/2/2024Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 5/2/2024 due to an increase in the total return index and volatility index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 5/2/2024 due to an increase in the total return index and volatility index.
E
Sell
4/17/2024Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 4/17/2024 due to a decline in the volatility index and total return index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 4/17/2024 due to a decline in the volatility index and total return index.
D
Sell
4/2/2024Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 4/2/2024 due to an increase in the volatility index and total return index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 4/2/2024 due to an increase in the volatility index and total return index.
E
Sell
3/12/2024Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 3/12/2024 due to a decline in the volatility index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 3/12/2024 due to a decline in the volatility index.
D
Sell
2/26/2024Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 2/26/2024 due to a major increase in the solvency index, growth index and volatility index. Earnings per share increased from -$0.0075 to -$0.0013, the quick ratio increased from 0.01 to 0.02, and EBIT increased 32.35% from -$760.5 to -$514.5.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 2/26/2024 due to a major increase in the solvency index, growth index and volatility index. Earnings per share increased from -$0.0075 to -$0.0013, the quick ratio increased from 0.01 to 0.02, and EBIT increased 32.35% from -$760.5 to -$514.5.
E
Sell
4/27/2023Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 4/27/2023 due to a decline in the volatility index and total return index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 4/27/2023 due to a decline in the volatility index and total return index.
D
Sell
3/14/2023Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
D
Sell
2/8/2023Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0102 to -$0.0376, EBIT declined 247.17% from -$940.6 to -$3.27M, and operating cash flow declined 88.05% from -$253.5 to -$476.7.
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0102 to -$0.0376, EBIT declined 247.17% from -$940.6 to -$3.27M, and operating cash flow declined 88.05% from -$253.5 to -$476.7.
D
Sell
6/29/2022Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 6/29/2022 due to a noticeable increase in the growth index, volatility index and solvency index. Operating cash flow increased 79.35% from -$1.54M to -$317.6, and earnings per share increased from -$0.0365 to -$0.0316.
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 6/29/2022 due to a noticeable increase in the growth index, volatility index and solvency index. Operating cash flow increased 79.35% from -$1.54M to -$317.6, and earnings per share increased from -$0.0365 to -$0.0316.
D
Sell
6/2/2022Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 6/2/2022 due to a major decline in the solvency index, growth index and total return index. Debt to equity increased from -0.42 to -0.08, the quick ratio declined from 0.6 to 0.12, and earnings per share declined from -$0.0239 to -$0.0365.
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 6/2/2022 due to a major decline in the solvency index, growth index and total return index. Debt to equity increased from -0.42 to -0.08, the quick ratio declined from 0.6 to 0.12, and earnings per share declined from -$0.0239 to -$0.0365.
D
Sell
5/16/2022Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from E+ on 05/16/2022.
BetterLife Pharma Inc. (BETR) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/5/2022Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell
4/20/2022Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 4/20/2022 due to a decline in the solvency index. The quick ratio declined from 1 to 0.6.
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 4/20/2022 due to a decline in the solvency index. The quick ratio declined from 1 to 0.6.
D
Sell
12/6/2021Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 12/6/2021 due to an increase in the total return index.
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 12/6/2021 due to an increase in the total return index.
D
Sell
11/23/2021Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 11/08/2021.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 11/08/2021.
D
Sell
9/28/2021Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 9/28/2021 due to a major decline in the solvency index, growth index and total return index. Debt to equity increased from -0.15 to 0.26, operating cash flow declined 52.47% from -$2.27M to -$3.47M, and EBIT declined 45.2% from -$1.88M to -$2.73M.
BetterLife Pharma Inc. (BETR) was downgraded to D- from D on 9/28/2021 due to a major decline in the solvency index, growth index and total return index. Debt to equity increased from -0.15 to 0.26, operating cash flow declined 52.47% from -$2.27M to -$3.47M, and EBIT declined 45.2% from -$1.88M to -$2.73M.
D
Sell
7/6/2020Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 7/6/2020 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.4724 to $0.0145, debt to equity declined from 0.03 to 0, and operating cash flow increased 14.12% from -$1.08M to -$925.3.
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 7/6/2020 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.4724 to $0.0145, debt to equity declined from 0.03 to 0, and operating cash flow increased 14.12% from -$1.08M to -$925.3.
D
Sell
6/26/2020Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 6/26/2020 due to an increase in the volatility index, total return index and solvency index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 6/26/2020 due to an increase in the volatility index, total return index and solvency index.
E
Sell
6/2/2020Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D on 6/2/2020 due to a major decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0114 to -$0.0472, debt to equity increased from 0.01 to 0.03, and the quick ratio declined from 8.22 to 2.94.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D on 6/2/2020 due to a major decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0114 to -$0.0472, debt to equity increased from 0.01 to 0.03, and the quick ratio declined from 8.22 to 2.94.
D
Sell
5/20/2020Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 5/20/2020 due to a noticeable increase in the growth index, volatility index and total return index.
BetterLife Pharma Inc. (BETR) was upgraded to D from D- on 5/20/2020 due to a noticeable increase in the growth index, volatility index and total return index.
D
Sell
2/28/2020Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 2/28/2020 due to an increase in the volatility index, total return index and valuation index.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 2/28/2020 due to an increase in the volatility index, total return index and valuation index.
E
Sell
2/12/2020Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 2/12/2020 due to a decline in the volatility index, growth index and total return index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 2/12/2020 due to a decline in the volatility index, growth index and total return index.
D
Sell
12/26/2019Upgraded
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 12/26/2019 due to a noticeable increase in the growth index. Operating cash flow increased 69.66% from -$3.41M to -$1.03M, earnings per share increased from -$0.021 to -$0.0114, and EBIT increased 44.91% from -$3.16M to -$1.74M.
BetterLife Pharma Inc. (BETR) was upgraded to D- from E+ on 12/26/2019 due to a noticeable increase in the growth index. Operating cash flow increased 69.66% from -$3.41M to -$1.03M, earnings per share increased from -$0.021 to -$0.0114, and EBIT increased 44.91% from -$3.16M to -$1.74M.
E
Sell
12/17/2019Downgrade
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 12/17/2019 due to a decline in the total return index and volatility index.
BetterLife Pharma Inc. (BETR) was downgraded to E+ from D- on 12/17/2019 due to a decline in the total return index and volatility index.
D
Sell
10/2/2019Upgraded
Pivot Pharmaceuticals Inc. (PVOT) was upgraded to D- from E+ on 10/2/2019 due to a substantial increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.02 to 13.17, and debt to equity declined from 0.95 to 0.01.
Pivot Pharmaceuticals Inc. (PVOT) was upgraded to D- from E+ on 10/2/2019 due to a substantial increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.02 to 13.17, and debt to equity declined from 0.95 to 0.01.
E
Sell
12/19/2018Downgrade
Pivot Pharmaceuticals Inc. (PVOT) was downgraded to E+ from D- on 12/19/2018 due to a significant decline in the efficiency index, growth index and solvency index. Earnings per share declined from -$0.0166 to -$0.04, net income declined 138.79% from -$1.41M to -$3.38M, and EBIT declined 19.07% from -$1.16M to -$1.38M.
Pivot Pharmaceuticals Inc. (PVOT) was downgraded to E+ from D- on 12/19/2018 due to a significant decline in the efficiency index, growth index and solvency index. Earnings per share declined from -$0.0166 to -$0.04, net income declined 138.79% from -$1.41M to -$3.38M, and EBIT declined 19.07% from -$1.16M to -$1.38M.
D
Sell
9/4/2018Upgraded
Pivot Pharmaceuticals Inc. (PVOT) was upgraded to D- from E on 9/4/2018 due to a significant increase in the efficiency index, solvency index and volatility index. Total capital increased 5,072.08% from $155.8 to $8.06M, and the quick ratio increased from 0.28 to 0.43.
Pivot Pharmaceuticals Inc. (PVOT) was upgraded to D- from E on 9/4/2018 due to a significant increase in the efficiency index, solvency index and volatility index. Total capital increased 5,072.08% from $155.8 to $8.06M, and the quick ratio increased from 0.28 to 0.43.
E
Sell
6/5/2018Upgraded
Pivot Pharmaceuticals Inc. (PVOT) was upgraded to E from E- on 6/5/2018 due to an increase in the valuation index and solvency index. Debt to equity declined from 1.11 to -4.43.
Pivot Pharmaceuticals Inc. (PVOT) was upgraded to E from E- on 6/5/2018 due to an increase in the valuation index and solvency index. Debt to equity declined from 1.11 to -4.43.
E
Sell
3/15/2018None
BetterLife Pharma Inc. (BETR) was downgraded to E- from U on 03/15/2018.
BetterLife Pharma Inc. (BETR) was downgraded to E- from U on 03/15/2018.
